Ketoprofen poly(lactide-co-glycolide) physical interaction studied by Brillouin spectroscopy and molecular dynamics simulations.


Journal

International journal of pharmaceutics
ISSN: 1873-3476
Titre abrégé: Int J Pharm
Pays: Netherlands
ID NLM: 7804127

Informations de publication

Date de publication:
30 Apr 2020
Historique:
received: 10 02 2020
revised: 09 03 2020
accepted: 14 03 2020
pubmed: 21 3 2020
medline: 16 1 2021
entrez: 21 3 2020
Statut: ppublish

Résumé

The performances of poly(lactic-co-glycolic acid) drug delivery systems are affected by the molecular interactions established between the drug and the polymer matrix as well as by the physical state of the drug embedded. Indeed, the drug may induce polymer plasticization with a drastic change in the release kinetics and medicinal product performances. The aim of this study was to better understand the interactions between poly(lactic-co-glycolic acid) and ketoprofen, the latter known to plasticize hydrophilic and hydrophobic polymers. Ketoprofen interacts with poly(lactic-co-glycolic acid) exerting a maximum plasticizing effect at weight fractions around 0.25. Higher ketoprofen amounts form heterogeneous mixtures with the non-soluble molecules dispersed in the matrix as crystals or amorphous domains, depending on the preparation method. Unexpectedly, the amorphous ketoprofen dispersed in the poly(lactic-co-glycolic acid) matrix is remarkably stable. H-bonding seems responsible for the glass transition temperature reduction and the limited solubility. Brillouin spectroscopy and molecular dynamics simulation data suggest that ketoprofen solubility increases with temperature and non-polar interactions are responsible for this phenomenon.

Identifiants

pubmed: 32194212
pii: S0378-5173(20)30219-2
doi: 10.1016/j.ijpharm.2020.119235
pii:
doi:

Substances chimiques

Biocompatible Materials 0
Polylactic Acid-Polyglycolic Acid Copolymer 1SIA8062RS
Polyglactin 910 34346-01-5
Ketoprofen 90Y4QC304K

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

119235

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Paolo Blasi (P)

Scuola del Farmaco e dei Prodotti della Salute, Università degli Studi di Camerino, 62032 Camerino, Italy.

Serena Casagrande (S)

Dipartimento di Scienze Farmaceutiche, Università degli Studi di Perugia, 06123 Perugia, Italy.

Alessandro Pedretti (A)

Dipartimento di Scienze Farmaceutiche "Pietro Pratesi", Università degli Studi di Milano, 20133 Milano, Italy.

Daniele Fioretto (D)

Dipartimento di Fisica e Geologia, Università degli Studi di Perugia, 06123 Perugia, Italy.

Giulio Vistoli (G)

Dipartimento di Scienze Farmaceutiche "Pietro Pratesi", Università degli Studi di Milano, 20133 Milano, Italy.

Silvia Corezzi (S)

Dipartimento di Fisica e Geologia, Università degli Studi di Perugia, 06123 Perugia, Italy. Electronic address: silvia.corezzi@unipg.it.

Articles similaires

Photosynthesis Ribulose-Bisphosphate Carboxylase Carbon Dioxide Molecular Dynamics Simulation Cyanobacteria
Vancomycin Polyesters Anti-Bacterial Agents Models, Theoretical Drug Liberation
Fucosyltransferases Drug Repositioning Molecular Docking Simulation Molecular Dynamics Simulation Humans
Receptor, Cannabinoid, CB1 Ligands Molecular Dynamics Simulation Protein Binding Thermodynamics

Classifications MeSH